The directory offers vital insights into 1,000 top global pharmaceutical and biotech companies, featuring key management, business activities, and more. It aids market research, strategic planning, ...

DOVER, DE, UNITED STATES, January 21, 2026 /EINPresswire.com/ -- The global pharmaceutical supply chain is currently ...

Vertex Pharmaceuticals Incorporated (VRTX) is a global biotechnology firm that discovers, develops, and commercializes transformative medicines for serious diseases, with a particular focus on ...

AI-assisted drug discovery isn’t just science fiction anymore, especially as biotechnology and biopharma firms embrace the AI age. Undoubtedly, it’s no mystery as to why many wish to be underweight in ...

The European pharmaceutical and biotechnology market offers vast opportunities. The European Pharmaceutical Directory aids businesses by providing up-to-date contact information, profiles, and ...

These two biotechs only have one marketable therapy each, but both have blockbuster potential.

North Carolina, ranked in the top five states for life sciences by Business Facilities, is home to a thriving ecosystem specializing in bio and pharmaceutical manufacturing. Propelled by a low cost of ...

Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Identify research insights to guide ...

During the first six months of this year, the pharmaceutical-biotech industry completed construction on a total of 31 new plants and research centers across North America During the first six months ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to take a look at where Ultragenyx Pharmaceutical, Inc. (NASDAQ:RARE) stands ...

Carter emphasizes that women are currently serving as primary “thought leaders” in the advancement of precision medicine . In ...

Now, it’s worth noting Stock Advisor’s total average return is 913 % — a market-crushing outperformance compared to 196% for ...